Now seeking abstract submissions for the following: 4.1-B Point-of-Care Diagnostic Assay for detection of SARS-CoV-2 virus; 4.1-C: Diagnostic Tests for detection of COVID-19 disease; 4.3 COVID-19 Vaccine; 4.4 Advanced Manufacturing Technologies. The total Government share of funding, including options, of any project awarded under this EZ-BAA shall be less than $750,000.
Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.